Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis

被引：6

作者：

Lanfant-Weybel, Karine ^{[1
]}

Lequerre, Thierry ^{[1
]}

Vittecoq, Olivier ^{[1
]}

机构：

[1] Hop Rouen, CHU Rouen, Serv Rhumatol, INSERM 905, F-76031 Rouen, France

来源：

PRESSE MEDICALE | 2009年 / 38卷 / 05期

关键词：

ANTITUMOR-NECROSIS-FACTOR; PLACEBO-CONTROLLED TRIAL; MAJOR CLINICAL-RESPONSE; DOUBLE-BLIND; PSORIATIC-ARTHRITIS; PLUS METHOTREXATE; INFLIXIMAB; THERAPY; ETANERCEPT; MULTICENTER;

D O I：

10.1016/j.lpm.2009.02.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) ore, with psoriatic arthritis, the most frequent rheumatic diseases. A better understanding of pathophysiology of these diseases had led to the development of new treatments refered os to biologic agents and, among them, TNF blocking agents have a major role. The knowledge of these drugs in terms of mechanisms of action, indications and potentials side effects has to be known to improve the efficacy/tolerance balance. Although these 3 anti-TNF alpha agents are currently used, new TNF blocking agents ore under evaluation and should increase the number of drugs available within the next months

引用

页码：774 / 787

页数：14

共 50 条

[1] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
Tandon, N.
Haas, S.
Waters, H.
Olson, W.
Bolge, S.
Gunnarsson, C.
[J]. VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
[2] METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
Deyab, G.
Hokstad, I.
Smastuen, M. C.
Agewall, S.
Hollan, I.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 704 - 704
[3] Treatment of ankylosing spondylitis with anti-TNFα agents
Bontoux, Daniel
Azais, Isabelle
Goupille, Philippe
[J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (4-5): : 981 - 992
[4] EFFECTS OF ANTI-TNF THERAPY ON MARKERS OF BONE HOMEOSTASIS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
Horvth, A.
Pusztai, A.
Gulyas, K.
Vancsa, A.
Vegh, E.
Bodnar, N.
Csomor, P.
Petho, Z.
Juhsaz, B.
Szentpetery, A.
Szamosi, S.
Bhattoa, H.
Szanto, S.
Szucs, G.
Nagy, Z.
Szekanecz, Z.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A37 - A37
[5] EFFECTS OF ANTI-TNF THERAPY ON MARKERS OF BONE HOMEOSTASIS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
Horvath, A.
Pusztai, A.
Gulyas, K.
Vancsa, A.
Vegh, E.
Bodnar, N.
Csomor, P.
Pethoe, Z.
Juhasz, B.
Szentpetery, A.
Szamosi, S.
Bhattoa, H. P.
Szanto, S.
Szuecs, G.
Nagy, Z.
Szekanecz, Z.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 175 - 175
[6] TREATMENT WITH ANTI-TNF BIOLOGICS IN PATIENT WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS DOES NOT INCREASE THE RISK OF MALIGNANCY
Fanto, M.
Peragallo, M.
Pietrosanti, M.
Sorgi, M. L.
Salemi, S.
D'Amelio, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 438 - 438
[7] Patients with ankylosing spondylitis eligibility for anti-TNF alpha treatment in the United Kingdom
Lebmeier, M.
Bains, M.
Koscielny, V.
Baxter, G.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 739 - 739
[8] Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
Haberhauer, Guenther
Strehblow, Christoph
Fasching, Peter
[J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (9-10) : 220 - 224
[9] A narrative literature review of the impact of anti-TNFα treatment on the occupational performance of people with rheumatoid arthritis or ankylosing spondylitis
McArthur, Margaret
Birt, Linda
Goodacre, Lynne
[J]. BRITISH JOURNAL OF OCCUPATIONAL THERAPY, 2013, 76 (10) : 456 - 469
[10] Treatment of ankylosing spondylitis with anti-TNFα agents -: Discussion
Serratrice, M. Georges
Bastin, M. Raymond
Godeau, M. Pierre
Bourel, M. Michel
Doury, M. Paul
Paolaggi, M. Jean-Baptiste
[J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (4-5): : 993 - 994

← 1 2 3 4 5 →